ReviewDrug safety2017

Safety Profile of Eslicarbazepine Acetate as Add-On Therapy in Adults with Refractory Focal-Onset Seizures: From Clinical Studies to 6 Years of Post-Marketing Experience.

Helena Gama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.